Home › Compare › EPYFF vs MRK

EPYFF vs MRK: Dividend Comparison 2026

EPYFF yields 105263.16% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPYFF wins by $8.064713171987811e+26M in total portfolio value
10 years
EPYFF
EPYFF
● Live price
105263.16%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.064713171987811e+26M
Annual income
$804,966,999,868,734,400,000,000,000,000,000.00
Full EPYFF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — EPYFF vs MRK

📍 EPYFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEPYFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EPYFF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EPYFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPYFF
Annual income on $10K today (after 15% tax)
$8,947,368.42/yr
After 10yr DRIP, annual income (after tax)
$684,221,949,888,424,200,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, EPYFF beats the other by $684,221,949,888,424,200,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPYFF + MRK for your $10,000?

EPYFF: 50%MRK: 50%
100% MRK50/50100% EPYFF
Portfolio after 10yr
$4.0323565859939053e+26M
Annual income
$402,483,499,934,367,200,000,000,000,000,000.00/yr
Blended yield
99.81%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EPYFF
No analyst data
Altman Z
-1039.0
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPYFF buys
0
MRK buys
0
No recent congressional trades found for EPYFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEPYFFMRK
Forward yield105263.16% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$8.064713171987811e+26M$30.7K ✓
Annual income after 10y$804,966,999,868,734,400,000,000,000,000,000.00 ✓$950.29
Total dividends collected$8.063727433132777e+26M ✓$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EPYFF vs MRK ($10,000, DRIP)

YearEPYFF PortfolioEPYFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,537,016$10,526,315.79$11,192$351.54+$10.53M → EPYFF
2$10,377,251,773$10,365,977,166.23$12,524$392.70+$10377.24M → EPYFF
3$9,552,044,282,229$9,540,940,622,831.33$14,015$438.65+$9552044.27M → EPYFF
4$8,217,919,074,277,338$8,207,698,386,895,354.00$15,682$489.96+$8217919074.26M → EPYFF
5$6,608,173,294,209,699,000$6,599,380,120,800,222,000.00$17,547$547.23+$6608173294209.68M → EPYFF
6$4,966,582,566,903,309,000,000$4,959,511,821,478,505,000,000.00$19,632$611.16+$4966582566903309.00M → EPYFF
7$3,488,939,161,660,980,000,000,000$3,483,624,918,314,393,500,000,000.00$21,963$682.53+$3488939161660979712.00M → EPYFF
8$2,290,823,651,613,942,000,000,000,000$2,287,090,486,710,964,800,000,000,000.00$24,571$762.18+$2.2908236516139422e+21M → EPYFF
9$1,405,904,046,772,744,300,000,000,000,000$1,403,452,865,465,517,400,000,000,000,000.00$27,486$851.08+$1.4059040467727442e+24M → EPYFF
10$806,471,317,198,781,100,000,000,000,000,000$804,966,999,868,734,400,000,000,000,000,000.00$30,745$950.29+$8.064713171987811e+26M → EPYFF

EPYFF vs MRK: Complete Analysis 2026

EPYFF — Stock

ePlay Digital Inc., through its subsidiary, Mobovivo Inc., provides a social game engine and content marketing platform to engage audiences in Canada. Its solutions integrate TV, video, sports, daily fantasy, and social games into multiplatform destinations and campaigns for brands, sports teams, and venues. The company also operates Klocked World, an augmented reality virtual sports app; Klocked Fitness app and Klocked Sportsnet app; Big Shot Basketball app; and Fan Freak, a sports gaming app. ePlay Digital Inc. is headquartered in Calgary, Canada.

Full EPYFF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this EPYFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPYFF vs SCHDEPYFF vs JEPIEPYFF vs OEPYFF vs KOEPYFF vs MAINEPYFF vs JNJEPYFF vs ABBVEPYFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.